Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-commerce, Drug Stores and Others) & Region for 2024 to ...

Axsome Therapeutics (NASDAQ:AXSM) said a long-term Phase 3 study of its drug AXS-12 for the treatment of narcolepsy with cataplexy has met its primary endpoint. The study showed AXS-12 was able to ...

Confirming an obstructive sleep apnea diagnosis involves an overnight stay at a sleep disorders center, but the sleep study ...

Statistically significant improvement in cognition compared to placebo (p=0.011, NSAQ) Statistically significant improvement in narcolepsy overall compared to placebo (p=0.024, PGI-C) Cataplexy ...

NUTLEY, N.J., Nov. 21, 2024 /PRNewswire/ -- Eisai Inc. announced today its sponsorship of the upcoming webinar, "Lessons Learned from Central Disorders of Hypersomnolence and Future Directions", a ...

Full survey results and methodology can be viewed via this link. Narcolepsy and idiopathic hypersomnia are chronic sleep disorders characterized by excessive daytime sleepiness and other serious ...

Within weeks, he submitted his findings to Cell, revealing a mutation in the hypocretin/orexin-2 receptor gene as the cause of canine narcolepsy. According to Yanagisawa, the journal’s editor ...

Narcolepsy is often misunderstood and misdiagnosed, leading to significant delays in treatment and poor quality of life for those affected. 1 This event will bring together experts in the field to ...

Narcolepsy often has symptoms and features similar to those found in psychiatric ... One way to help yourself understand your sleep patterns is to keep a journal of your symptoms, noting: When your ...